Down Syndrome (DS) Terminated Phase 3 Trials for Donepezil (DB00843)
Also known as: Downs Syndrome / Down's Syndrome / Trisomy 21 / Down Syndrome / Trisomy 21 (morphologic abnormality) / Trisomy 21 NOS / (Down's syndrome - trisomy 21) or (mongolism) or (trisomy 21) or (trisomy 22) / Syndrome Down's / Mongolism / Down's syndrome NOS (disorder) / Down's syndrome NOS / Complete trisomy 21 syndrome (disorder)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0061020 (Down Syndrome (DS)) | Terminated | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00754052 | Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17 | Treatment | |
| NCT00754013 | Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10 | Treatment |